(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD
Pharma Lab Global

15% off first order with code: 1storder

Pharma Lab Global
99%+ Quality Guaranteed
Pharma Lab Global
Pay by crypto get 10% discount
Pharma Lab Global
Shipping Protection
Pharma Lab Global
Fast Order Process

ARA-290 Peptide Vial 2mg Denmark

ARA-290 peptide is a nonerythropoietic peptide created from erythropoietin. It has demonstrated encouraging benefits in improving metabolic management and relieving neuropathic symptoms in people with type 2 diabetes. Derived from the tertiary structure of erythropoietin, it has been found to provide long-term relief of neuropathic pain and reduce systemic inflammation. ARA-290 has also shown tissue-protective and tissue-regenerative properties, making it a potential therapeutic option for a variety of diseases.


SKU PLG: ARA-290 Vial Categories , Tag


ARA-290 Peptide Vial 2mg

In research investigations, ARA-290 peptide vial Denmark has been proven to lower HbAlc and improve cholesterol, modify neuropathic pain, induce wound repair, and have anti-inflammatory characteristics.



Molecular Formula: C51H84N16O21

Molecular Weight: 1257.3 g/mol

Size: 2mg


Protection and Tissue Health

ARA-290 treatment enhances the health and longevity of islet cells in the body by lowering macrophage activation, according to mouse studies. Furthermore, islet cells regulate blood sugar more well than exogenous insulin, resulting in fewer complications. Although islet cells do not tolerate transplantation well, study with Denmark ARA-290 suggests that this peptide can help them live longer [1].

According to Denmark research, the ARA-290 nasal peptide protects tissue from natural inflammatory reactions. Animal studies have demonstrated that this results in faster wound healing, repair and lower mortality.

Preventing Disease

Rodent studies show that ARA290 nasal prolongs cell life and helps endothelial colony-forming cells (ECFCs) develop and mend blood arteries. Protecting these cells may help to prevent retinal ischemia, which is the major cause of blindness in Western countries [2].

Additional research has shown that the peptide ARA290 promotes the migration, proliferation, and health of endothelial cell-derived fibroblasts (ECFCs), explicitly targeting areas of the vasculature that require repair. In medicine, ara290 has the capacity to represent the future of protein synthesis, tissue regeneration, and hormone production.

Immune System Booster

According to recent clinical studies, ARA-290 may help enhance the immune system. TPR is expressed on a variety of immune cells, including mast cells, lymphocytes, dendritic cells, and macrophages.

According to Denmark scientific findings, ara-290 can bind to this TPR on immune cells and directly change their activity. When ARA 290 enhances TPR, it dramatically inhibits the release of proinflammatory cytokines like IL-6. This makes illnesses less severe and prevents them from beginning in the first place [3].

Pain Relief

Research reveals that targeting the IRR (innate repair receptor) can lessen inflammation and improve neuropathic pain. Denmark einsteinerupload of. Furthermore, animal studies have shown that the ARA 290 peptide can reduce pain caused or related with, but not limited to, multiple sclerosis, diabetes, and amputation by acting on this specific receptor.

Treatment with ARA290 can also increase the amount of small nerve fibres, which are typically associated with some autoimmune diseases, resulting in significant pain relief. Furthermore, animal studies indicate that a high dose of ARA-290 nasal could be a beneficial therapy for nerve damage caused by illnesses such as HIV, diabetes, thyroid disease, and celiac disease [4].


The novel method of reducing nerve pain used by ARA-290 has attracted notice. Furthermore, the peptide’s immune-modulating capabilities, ability to induce wound repair, and potential to protect the vasculature during inflammatory reactions have piqued researchers’ interest. The ability of ARA-290 to modulate neuropathic pain is based on the most recent research. The peptide is currently being studied to treat diabetic neuropathy and sarcoid neuropathy. ARA-290 is also being studied in Denmark clinical trials to treat systemic lupus erythematosus, multiple sclerosis, HIV, celiac disease, and other painful illnesses. Furthermore, research indicates that patients with inflammatory bowel disease (IBD) are becoming more interested in employing ARA-290 as a potential disease-modifying medication.


[1] https://pubmed.ncbi.nlm.nih. gov/24555851/

[2] https://pubmed.ncbi.nlm.nih. gov/30876881/

[3] https://www.sciencedirect.com/ science/article/abs/pii/S0196978 116300031

[4] https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC4365069/

Buy ARA-290 Peptide Vial 2mg

Pharma Lab Global Denmark is one of the best locations to purchase high purity ARA 290 peptide vial for research use. Pharma Lab Global is a trusted supplier of peptides and sarms worldwide. You also have the option to buy ARA-290 Pre-Mixed Pen or ARA-290 nasal spray. Buy from Pharma Lab Global Denmark today!


DISCLAIMER: All products sold by Pharma Lab Global Denmark are for in-vitro research and laboratory use only. These products are not designed for use or consumption by humans or animals. Nothing on this Website is intended to diagnose, heal, treat, cure, mitigate or prevent disease. By purchasing from our Website the buyer accepts and acknowledges the risks involved with consumption and handling of these products. All articles and product information provided on this Website are for informational and educational purposes only. All products are to be handled by qualified and properly trained research or laboratory professionals only.

Additional information


2mg Vial, Kit = 2mg vial, bac water, syringes